248 related articles for article (PubMed ID: 33065603)
21. Research Status and Molecular Mechanism of the Traditional Chinese Medicine and Antitumor Therapy Combined Strategy Based on Tumor Microenvironment.
Zhang Y; Lou Y; Wang J; Yu C; Shen W
Front Immunol; 2020; 11():609705. PubMed ID: 33552068
[TBL] [Abstract][Full Text] [Related]
22. Traditional Chinese Medicine Treatment as Adjuvant Therapy in Completely Resected Stage IB-IIIA Non-Small-Cell Lung Cancer: Study Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.
Jiang Y; Liu LS; Shen LP; Liu JX; Jiang GN; Gu AQ; Li HC; Li Q; Li HG; Huang PX
Clin Lung Cancer; 2019 Sep; 20(5):e541-e547. PubMed ID: 31230892
[TBL] [Abstract][Full Text] [Related]
23. [Discussion of relationship between quality of life and clinical effect assessment of malignant tumor treated with traditional Chinese medicine].
Que HF; Chen HF; Xu JN; Liu S; Lu DM; Tang HJ
Zhong Xi Yi Jie He Xue Bao; 2005 Jul; 3(4):253-6. PubMed ID: 16009097
[TBL] [Abstract][Full Text] [Related]
24. [Research progress on oxaliplatin-induced neurotoxicity in traditional Chinese medicine (TCM) and western medical cognition and prevention and treatment by TCM].
Zhang MM; Gong ZC; Chen YY
Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(17):4610-4619. PubMed ID: 37802800
[TBL] [Abstract][Full Text] [Related]
25. [Evidence-based medicine and treatment of lung cancer].
Xu ZY
Zhong Xi Yi Jie He Xue Bao; 2003 Jul; 1(2):151-4. PubMed ID: 15339594
[TBL] [Abstract][Full Text] [Related]
26. Application of Traditional Chinese Medicines as Personalized Therapy in Human Cancers.
Wang S; Long S; Wu W
Am J Chin Med; 2018; 46(5):953-970. PubMed ID: 29986595
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic analysis of stage III-IV non-small cell lung cancer patients treated by traditional chinese medicine].
Zhou DH; Lin LZ; Zhou YQ; Luo RC; Liu KF; Jia YJ; Chen JY; Niu XW; Su BR; Lu J; Wang ST
Ai Zheng; 2005 Oct; 24(10):1252-6. PubMed ID: 16219143
[TBL] [Abstract][Full Text] [Related]
28. Molecular targets of β-elemene, a herbal extract used in traditional Chinese medicine, and its potential role in cancer therapy: A review.
Zhai B; Zhang N; Han X; Li Q; Zhang M; Chen X; Li G; Zhang R; Chen P; Wang W; Li C; Xiang Y; Liu S; Duan T; Lou J; Xie T; Sui X
Biomed Pharmacother; 2019 Jun; 114():108812. PubMed ID: 30965237
[TBL] [Abstract][Full Text] [Related]
29. Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial.
Yang XB; Wu WY; Long SQ; Deng H; Pan ZQ; He WF; Zhou YS; Liao GY; Li QP; Xiao SJ; Cai JZ
Trials; 2015 Apr; 16():146. PubMed ID: 25873045
[TBL] [Abstract][Full Text] [Related]
30. Traditional Chinese medicine in the treatment of breast cancer.
Cohen I; Tagliaferri M; Tripathy D
Semin Oncol; 2002 Dec; 29(6):563-74. PubMed ID: 12516039
[TBL] [Abstract][Full Text] [Related]
31. Clinical experience of chinese herbal medicine ameliorates dermatologic events from epidermal growth factor receptor inhibitors for lung cancer: A case series.
Hung YC; Chin CY; Lee YC; Chen YH; Tsai MY
Explore (NY); 2019; 15(5):363-370. PubMed ID: 30497918
[TBL] [Abstract][Full Text] [Related]
32. Association Between Use of Traditional Chinese Medicine Herbal Therapy and Survival Outcomes in Patients With Stage II and III Colorectal Cancer: A Multicenter Prospective Cohort Study.
Xu Y; Mao JJ; Sun L; Yang L; Li J; Hao Y; Li H; Hou W; Chu Y; Bai Y; Jia X; Wang J; Shen L; Zhang Y; Wang J; Liu J; Yang Y
J Natl Cancer Inst Monogr; 2017 Nov; 2017(52):. PubMed ID: 29140496
[TBL] [Abstract][Full Text] [Related]
33. Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.
Li H
J Ethnopharmacol; 2020 Apr; 251():112442. PubMed ID: 31891799
[TBL] [Abstract][Full Text] [Related]
34. Traditional Chinese Medicine for Cancer Treatment.
Liu Y; Fang C; Luo J; Gong C; Wang L; Zhu S
Am J Chin Med; 2024; 52(3):583-604. PubMed ID: 38716616
[TBL] [Abstract][Full Text] [Related]
35. Liver Injury by the Traditional Chinese Medicine Hanshirento, Zenshikunshito, and Ninjin'yoeito in a Patient with Lung Cancer: Probable Causality Assessed by the Updated Roussel Uclaf Causality Assessment Method.
Funakoshi H; Momo K; Kashima A; Ida H; Miyata Y; Sagara H; Sasaki T
Integr Cancer Ther; 2021; 20():15347354211004734. PubMed ID: 33769124
[TBL] [Abstract][Full Text] [Related]
36. The triangular relationship between traditional Chinese medicines, intestinal flora, and colorectal cancer.
Zou Y; Wang S; Zhang H; Gu Y; Chen H; Huang Z; Yang F; Li W; Chen C; Men L; Tian Q; Xie T
Med Res Rev; 2024 Mar; 44(2):539-567. PubMed ID: 37661373
[TBL] [Abstract][Full Text] [Related]
37. [Effect of traditional Chinese medicine treatment as maintenance therapy on regulating the serum concentration of sCTLA-4 in patients with advanced non-small-cell lung cancer and its relationship with prognosis].
Jiang Y; Wu LB; Shen LP; Zhang P; Jiang WJ; Tian JH; Liu LS
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):757-762. PubMed ID: 27784460
[No Abstract] [Full Text] [Related]
38. Effectiveness of Combined Treatment with Traditional Chinese Medicine and Western Medicine on the Prognosis of Patients with Breast Cancer.
Lee YC; Chen YH; Huang YC; Lee YF; Tsai MY
J Altern Complement Med; 2020 Sep; 26(9):833-840. PubMed ID: 32924556
[No Abstract] [Full Text] [Related]
39. Traditional Chinese medicine and lung cancer--From theory to practice.
Li Z; Feiyue Z; Gaofeng L
Biomed Pharmacother; 2021 May; 137():111381. PubMed ID: 33601147
[TBL] [Abstract][Full Text] [Related]
40. [Significance and necessity of developing quality of life questionnaire for cancer patients adapting to traditional Chinese medicine].
You J
Zhong Xi Yi Jie He Xue Bao; 2006 Sep; 4(5):473-7. PubMed ID: 16965739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
